FDA Import Refusal 065-0402209-3/11/1 — Zhejiang Guobang Pharmaceutical Co., Ltd

Zhejiang Guobang Pharmaceutical Co., Ltd — FEI 3008617115

The FDA refused shipment 065-0402209-3/11/1 from Zhejiang Guobang Pharmaceutical Co., Ltd (China) on May 16, 2022. The refused product falls under Drugs and Biologics — CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charges: 2280,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 16, 2022
Country
China
Product Category
Drugs and Biologics
Product Code
61FCS55 CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
Charges
2280,3280